Global Intrathecal Pumps Market Report and Forecast 2023-2031

Global Intrathecal Pumps Market Report and Forecast 2023-2031


Global Intrathecal Pumps Market Outlook:


The global Intrathecal pumps market value was USD 338.2 million in 2022, driven by the increasing chronic pain conditions, including neuropathic pain and cancer-related pain across the globe. The market size is anticipated to grow at a CAGR of 5.1% during the forecast period of 2023-2031 to achieve a value of USD 529.2 million by 2031.

Introduction

Intrathecal pumps, also known as spinal infusion pumps, are medical devices used to deliver medications directly into the intrathecal space surrounding the spinal cord. These pumps are surgically implanted and connected to a catheter that delivers medication to the targeted area. Intrathecal pumps are primarily used for pain management and the delivery of medications for the treatment of chronic pain, spasticity, and other neurological condition.

Key Trends in the Intrathecal Pumps Market


Some key trends involved in the Intrathecal Pumps market are as follows:

Growing Demand for Pain Management: Chronic pain is a significant global health concern, and there is a growing demand for effective pain management solutions. Intrathecal pumps offer a targeted and controlled delivery of pain medications directly to the spinal cord, providing long-term relief for patients suffering from chronic pain. The increasing prevalence of chronic pain conditions, such as neuropathic pain and cancer-related pain, is driving the demand for intrathecal pumps.
Technological Advancements: The intrathecal pump market is witnessing continuous technological advancements aimed at improving the functionality, reliability, and ease of use of these devices. Manufacturers are focusing on developing advanced pump systems with features such as programmable dosing, remote monitoring capabilities, and improved battery life. These advancements enhance the overall patient experience and make the therapy more convenient for healthcare providers.
Expansion of Indications: Initially, intrathecal pumps were primarily used for pain management. However, their applications have expanded to include the treatment of spasticity, movement disorders, and certain neurological conditions such as multiple sclerosis and dystonia. The broader range of indications has increased the market potential for intrathecal pumps and opened up new opportunities for both patients and healthcare providers.
Growing Preference for Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures in healthcare, driven by factors such as reduced recovery time, lower risk of complications, and improved patient outcomes. Intrathecal pump implantation is a minimally invasive procedure that offers targeted drug delivery without the need for frequent oral or intravenous medications. The increasing focus on minimally invasive approaches is expected to drive the adoption of intrathecal pumps.

Intrathecal Pumps Market Segmentations


Market Breakup by Type

Baclofen
Bupivacaine
Clonidine
Morphine
Hydromorphone
Fentanyl
Ziconotide
Others
Market Breakup by Applications

Pain Management
Cancer Pain
Reflex Sympathetic Dystrophy
Causalgia
Arachnoiditis
Chronic Pancreatitis
Failed Back Surgery Syndrome
Others
Spasticity Management
Cerebral Palsy
Multiple Sclerosis
Stroke
Brain Injury
Spinal Cord Injury
Others
Market Breakup by End User

Clinics
Hospitals
Long Term Care Centers
Alternate Care Centers
Others
Market Breakup by Region

North America
United States of America
Canada
Europe
United Kingdom
Germany
France
Italy
Others
Asia Pacific
China
Japan
India
ASEAN
Australia
Others
Latin America
Brazil
Argentina
Mexico
Others
Middle East and Africa
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others

Intrathecal Pumps Market Scenario


The market for intrathecal pumps, also known as spinal infusion pumps, is experiencing significant growth due to the increasing demand for effective pain management solutions and the expanding applications of these devices. Intrathecal pumps are surgically implanted medical devices that deliver medications directly to the intrathecal space surrounding the spinal cord, offering targeted and controlled drug delivery for patients with chronic pain and neurological conditions.

The market is driven by factors such as the rising prevalence of chronic pain conditions, including neuropathic pain and cancer-related pain, which require long-term pain management solutions. The limitations of conventional oral and intravenous medications in providing effective pain relief have led to the growing adoption of intrathecal pumps. These devices offer the advantage of delivering medications directly to the spinal cord, resulting in improved pain control and reduced systemic side effects.

Technological advancements in intrathecal pump systems have also contributed to the market's growth. Manufacturers are developing advanced pump models with features like programmable dosing, remote monitoring capabilities, and improved battery life. These innovations enhance the functionality, convenience, and patient experience with intrathecal pump therapy.

Intrathecal Pumps Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

Tricumed Medizintechnik GmbH
Codman and Shurtleff
Teleflex, Inc.
Flowonix Medical, Inc.
Zimmer Biomet
Medtronic
Medallion Therapeutics
Johnson and Johnson Services, Inc.
DURECT Corporation
BD


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Intrathecal Pumps Market Overview
3.1 Global Intrathecal Pumps Market Historical Value (2016-2022)
3.2 Global Intrathecal Pumps Market Forecast Value (2023-2031)
4 Global Intrathecal Pumps Market Landscape
4.1 Global Intrathecal Pumps Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Intrathecal Pumps Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Intrathecal Pumps Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Intrathecal Pumps Market Segmentation
6.1 Global Intrathecal Pumps Market by Type
6.1.1 Market Overview
6.1.2 Baclofen
6.1.3 Bupivacaine
6.1.4 Clonidine
6.1.5 Morphine
6.1.6 Hydromorphone
6.1.7 Fentanyl
6.1.8 Ziconotide
6.1.9 Others
6.2 Global Intrathecal Pumps Market by Applications
6.2.1 Market Overview
6.2.2 Pain Management
6.2.2.1 Cancer Pain
6.2.2.2 Reflex Sympathetic Dystrophy
6.2.2.3 Causalgia
6.2.2.4 Arachnoiditis
6.2.2.5 Chronic Pancreatitis
6.2.2.6 Failed Back Surgery Syndrome
6.2.2.7 Others
6.2.3 Spasticity Management
6.2.3.1 Cerebral Palsy
6.2.3.2 Multiple Sclerosis
6.2.3.3 Stroke
6.2.3.4 Brain Injury
6.2.3.5 Spinal Cord Injury
6.2.3.6 Others
6.3 Global Intrathecal Pumps Market by End User
6.3.1 Market Overview
6.3.2 Clinics
6.3.3 Hospitals
6.3.4 Long Term Care Centers
6.3.5 Alternate Care Centers
6.3.6 Others
6.4 Global Intrathecal Pumps Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Intrathecal Pumps Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Intrathecal Pumps Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Intrathecal Pumps Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Intrathecal Pumps Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Intrathecal Pumps Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Tricumed Medizintechnik GmbH
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Codman and Shurtleff
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Teleflex, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Flowonix Medical, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Zimmer Biomet
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Medtronic
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medallion Therapeutics
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Johnson and Johnson Services, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 DURECT Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BD
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Intrathecal Pumps Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings